Genetic mechanisms of susceptibility to oxidative lung injury in mice

Free Radical Biology and Medicine

Volumn 42, Issue 4, 2007, Pages 433-445

  Cho, Hye Youn ^a   Kleeberger, Steven R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Candidate gene; Inbred mice; Linkage analysis; Lung; Quantitative trait locus; Susceptibility

Indexed keywords

ACID; ANTIFIBROTIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BLEOMYCIN; GLUCOCORTICOID; IMMUNOMODULATING AGENT; NICKEL; OZONE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR; ZINC;

ACUTE TOXICITY; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ANTIOXIDANT ACTIVITY; BIOLOGICAL MODEL; DISEASE ASSOCIATION; FIBROSING ALVEOLITIS; FLY ASH; GENE DELETION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; HYPEROXIA; IMMUNITY; INFLAMMATORY CELL; LUNG DISEASE; LUNG FIBROSIS; LUNG INJURY; LUNG TOXICITY; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOUSE STRAIN; NONHUMAN; OXIDATIVE STRESS; PARTICULATE MATTER; PNEUMONIA; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RADIATION; REVIEW;

ANIMALS; BASE SEQUENCE; GENETIC PREDISPOSITION TO DISEASE; LUNG DISEASES; MICE; OXIDATIVE STRESS; SPECIES SPECIFICITY;

MUS;

EID: 33846516962     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.11.021     Document Type: Review

References (117)

1. Saugstad O.D. Bronchopulmonary dysplasia-Oxidative stress and antioxidants. Semin. Neonatol. 8 (2003) 39-49
2. Fridovich I. Oxygen toxicity: a radical explanation. J. Exp. Biol. 201 Pt. 8 (1998) 1203-1209
3. Halliwell B., Gutteridge J.M., and Cross C.E. Free radicals, antioxidants, and human disease: where are we now?. J. Lab. Clin. Med. 119 (1992) 598-620
4. Leff J.A., Parsons P.E., Day C.E., Moore E.E., Moore F.A., Oppegard M.A., and Repine J.E. Increased serum catalase activity in septic patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 146 (1992) 985-989
5. Asikainen T.M., and White C.W. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid. Redox Signal. 6 (2004) 155-167
6. Kleeberger S.R. Genetic aspects of pulmonary responses to inhaled pollutants. Exp. Toxicol. Pathol. 57 Suppl. 1 (2005) 147-153
7. Moore K.J., and Nagle D.L. Complex trait analysis in the mouse: the strengths, the limitations and the promise yet to come. Annu. Rev. Genet. 34 (2000) 653-686
8. Colilla S., Nicolae D., Pluzhnikov A., Blumenthal M.N., Beaty T.H., Bleecker E.R., Lange E.M., Rich S.S., Meyers D.A., Ober C., and Cox N.J. Evidence for gene-environment interactions in a linkage study of asthma and smoking exposure. J. Allergy Clin. Immunol. 111 (2003) 840-846
9. Wilk J.B., DeStefano A.L., Arnett D.K., Rich S.S., Djousse L., Crapo R.O., Leppert M.F., Province M.A., Cupples L.A., Gottlieb D.J., and Myers R.H. A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. Am. J. Respir. Crit. Care Med. 167 (2003) 1528-1533
10. Liao G., Wang J., Guo J., Allard J., Cheng J., Ng A., Shafer S., Puech A., McPherson J.D., Foernzler D., Peltz G., and Usuka J. In silico genetics: identification of a functional element regulating H2-Ealpha gene expression. Science 306 (2004) 690-695
11. Pletcher M.T., McClurg P., Batalov S., Su A.I., Barnes S.W., Lagler E., Korstanje R., Wang X., Nusskern D., Bogue M.A., Mural R.J., Paigen B., and Wiltshire T. Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol. 2 (2004) e393
12. Maruyama R., Aoki F., Toyota M., Sasaki Y., Akashi H., Mita H., Suzuki H., Akino K., Ohe-Toyota M., Maruyama Y., Tatsumi H., Imai K., Shinomura Y., and Tokino T. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res. 66 (2006) 4574-4583
13. Tostivint H., Joly L., Lihrmann I., Parmentier C., Lebon A., Morisson M., Calas A., Ekker M., and Vaudry H. Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. Proc. Natl. Acad. Sci. USA 103 (2006) 2237-2242
14. Bell D.A., Thompson C.L., Taylor J., Miller C.R., Perera F., Hsieh L.L., and Lucier G.W. Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ. Health Perspect. 98 (1992) 113-117
15. Hutyrova B., Pantelidis P., Drabek J., Zurkova M., Kolek V., Lenhart K., Welsh K.I., DuBois R.M., and Petrek M. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 165 (2002) 148-151
16. Nonas S.A., Finigan J.H., Gao L., and Garcia J.G. Functional genomic insights into acute lung injury: role of ventilators and mechanical stress. Proc. Am. Thorac. Soc. 2 (2005) 188-194
17. Schurmann M., Reichel P., Muller-Myhsok B., Schlaak M., Muller-Quernheim J., and Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am. J. Respir. Crit. Care Med. 164 (2001) 840-846
18. Hoffjan S., Stemmler S., Parwez Q., Petrasch-Parwez E., Arinir U., Rohde G., Reinitz-Rademacher K., Schultze-Werninghaus G., Bufe A., and Epplen J.T. Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease. BMC Med. Genet. 6 (2005) 34
19. Ito I., Nagai S., Handa T., Muro S., Hirai T., Tsukino M., and Mishima M. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am. J. Respir. Crit. Care Med. 172 (2005) 1378-1382
20. Marshall R.P., Webb S., Hill M.R., Humphries S.E., and Laurent G.J. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest 121 (2002) 68S-69S
21. Rohde G., Klein W., Arinir U., Hagedorn M., Duerig N., T T.B., Gillissen A., Schultze-Werninghaus G., and J T.E. Association of the ASP299GLY TLR4 polymorphism with COPD. Respir. Med. 100 (2006) 892-896
22. Witte J.S., Palmer L.J., O'Connor R.D., Hopkins P.J., and Hall J.M. Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur. J. Hum. Genet. 10 (2002) 82-85
23. Yang G., Shu X.O., Ruan Z.X., Cai Q.Y., Jin F., Gao Y.T., and Zheng W. Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma. Cancer 103 (2005) 52-58
24. Bauer A.K., Malkinson A.M., and Kleeberger S.R. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am. J. Physiol. Lung Cell. Mol. Physiol. 287 (2004) L685-L703
25. Pryor W.A., Squadrito G.L., and Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic. Biol. Med. 19 (1995) 935-941
26. Uysal N., and Schapira R.M. Effects of ozone on lung function and lung diseases. Curr. Opin. Pulm. Med. 9 (2003) 144-150
27. Bell M.L., McDermott A., Zeger S.L., Samet J.M., and Dominici F. Ozone and short-term mortality in 95 US urban communities, 1987-2000. JAMA 292 (2004) 2372-2378
28. Delfino R.J., Murphy-Moulton A.M., and Becklake M.R. Emergency room visits for respiratory illnesses among the elderly in Montreal: association with low level ozone exposure. Environ. Res. 76 (1998) 67-77
29. Parodi S., Vercelli M., Garrone E., Fontana V., and Izzotti A. Ozone air pollution and daily mortality in Genoa, Italy between 1993 and 1996. Public Health 119 (2005) 844-850
30. Peel J.L., Tolbert P.E., Klein M., Metzger K.B., Flanders W.D., Todd K., Mulholland J.A., Ryan P.B., and Frumkin H. Ambient air pollution and respiratory emergency department visits. Epidemiology 16 (2005) 164-174
31. Penttinen P., Tiittanen P., and Pekkanen J. Mortality and air pollution in metropolitan Helsinki, 1988-1996. Scand. J. Work Environ. Health 30 Suppl. 2 (2004) 19-27
32. Servais S., Boussouar A., Molnar A., Douki T., Pequignot J.M., and Favier R. Age-related sensitivity to lung oxidative stress during ozone exposure. Free Radic. Res. 39 (2005) 305-316
33. Frampton M.W., Morrow P.E., Torres A., Voter K.Z., Whitin J.C., Cox C., Speers D.M., Tsai Y., and Utell M.J. Effects of ozone on normal and potentially sensitive human subjects: Part II. Airway inflammation and responsiveness to ozone in nonsmokers and smokers. Res. Rep. Health Eff. Inst. (1997) 39-72 discussion 81-99
34. Bosson J., Stenfors N., Bucht A., Helleday R., Pourazar J., Holgate S.T., Kelly F.J., Sandstrom T., Wilson S., Frew A.J., and Blomberg A. Ozone-induced bronchial epithelial cytokine expression differs between healthy and asthmatic subjects. Clin. Exp. Allergy 33 (2003) 777-782
35. Mudway I.S., Stenfors N., Blomberg A., Helleday R., Dunster C., Marklund S.L., Frew A.J., Sandstrom T., and Kelly F.J. Differences in basal airway antioxidant concentrations are not predictive of individual responsiveness to ozone: a comparison of healthy and mild asthmatic subjects. Free Radic. Biol. Med. 31 (2001) 962-974
36. Bergamaschi E., De Palma G., Mozzoni P., Vanni S., Vettori M.V., Broeckaert F., Bernard A., and Mutti A. Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am. J. Respir. Crit. Care Med. 163 (2001) 1426-1431
37. Romieu I., Sienra-Monge J.J., Ramirez-Aguilar M., Moreno-Macias H., Reyes-Ruiz N.I., Estela del Rio-Navarro B., Hernandez-Avila M., and London S.J. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 59 (2004) 8-10
38. Broeckaert F., Clippe A., Wattiez R., Falmagne P., and Bernard A. Lung hyperpermeability, Clara-cell secretory potein (CC16), and susceptibility to ozone of five inbred strains of mice. Inhal. Toxicol. 15 (2003) 1209-1230
39. Goldstein B.D., Lai L.Y., Ross S.R., and Cuzzi-Spada R. Susceptibility of inbred mouse strains to ozone. Arch. Environ. Health 27 (1973) 412-413
40. Kleeberger S.R., Bassett D.J., Jakab G.J., and Levitt R.C. A genetic model for evaluation of susceptibility to ozone-induced inflammation. Am. J. Physiol. 258 (1990) L313-L320
41. Kleeberger S.R., Levitt R.C., and Zhang L.Y. Susceptibility to ozone-induced inflammation. I. Genetic control of the response to subacute exposure. Am. J. Physiol. 264 (1993) L15-L20
42. Kleeberger S.R., Levitt R.C., and Zhang L.Y. Susceptibility to ozone-induced inflammation: II. Separate loci control responses to acute and subacute exposures. Am. J. Physiol. 264 (1993) L21-L26
43. Kleeberger S.R., Reddy S., Zhang L.Y., and Jedlicka A.E. Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am. J. Respir. Cell Mol. Biol. 22 (2000) 620-627
44. Savov J.D., Whitehead G.S., Wang J., Liao G., Usuka J., Peltz G., Foster W.M., and Schwartz D.A. Ozone-induced acute pulmonary injury in inbred mouse strains. Am. J. Respir. Cell Mol. Biol. 31 (2004) 69-77
45. Zhang L.Y., Levitt R.C., and Kleeberger S.R. Differential susceptibility to ozone-induced airways hyperreactivity in inbred strains of mice. Exp. Lung Res. 21 (1995) 503-518
46. Kleeberger S.R., Levitt R.C., Zhang L.Y., Longphre M., Harkema J., Jedlicka A., Eleff S.M., DiSilvestre D., and Holroyd K.J. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat. Genet. 17 (1997) 475-478
47. Cho H.Y., Zhang L.Y., and Kleeberger S.R. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 280 (2001) L537-L546
48. Cho, H.Y.; Morgan, D.; Bauer, A.K.; Kleeberger, S.R. Signal transduction pathways of tumor necrosis factor-mediated lung injury induced by ozone. Am. J. Respir. Crit. Med. In press.
49. Yang I.A., Holz O., Jorres R.A., Magnussen H., Barton S.J., Rodriguez S., Cakebread J.A., Holloway J.W., and Holgate S.T. Association of tumour necrosis factor-alpha polymorphisms and ozone-induced change in lung function. Am. J. Respir. Crit. Care Med. 171 (2005) 171-176
50. Matheson M.C., Ellis J.A., Raven J., Walters E.H., and Abramson M.J. Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease. J. Hum. Genet. 51 (2006) 196-203
51. Kleeberger S.R., and Hudak B.B. Acute ozone-induced change in airway permeability: role of infiltrating leukocytes. J. Appl. Physiol. 72 (1992) 670-676
52. Reinhart P.G., Bassett D.J., and Bhalla D.K. The influence of polymorphonuclear leukocytes on altered pulmonary epithelial permeability during ozone exposure. Toxicology 127 (1998) 17-28
53. Poltorak A., He X., Smirnova I., Liu M.Y., VanHuffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
54. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., and Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1 (2000) 398-401
55. Wang X., Moser C., Louboutin J.P., Lysenko E.S., Weiner D.J., Weiser J.N., and Wilson J.M. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol. 168 (2002) 810-815
56. Kopp E.B., and Medzhitov R. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11 (1999) 13-18
57. Li X.Y., Donaldson K., and MacNee W. Lipopolysaccharide-induced alveolar epithelial permeability: the role of nitric oxide. Am. J. Respir. Crit. Care Med. 157 (1998) 1027-1033
58. Prows D.R., Daly M.J., Shertzer H.G., and Leikauf G.D. Ozone-induced acute lung injury: genetic analysis of F(2) mice generated from A/J and C57BL/6J strains. Am. J. Physiol. 277 (1999) L372-L380
59. Prows D.R., Shertzer H.G., Daly M.J., Sidman C.L., and Leikauf G.D. Genetic analysis of ozone-induced acute lung injury in sensitive and resistant strains of mice. Nat. Genet. 17 (1997) 471-474
60. Dockery D.W. Epidemiologic study design for investigating respiratory health effects of complex air pollution mixtures. Environ. Health Perspect. 101 Suppl. 4 (1993) 187-191
61. Gong H., Linn W.S., Terrell S.L., Anderson K.R., Clark K.W., Sioutas C., Cascio W.E., Alexis N., and Devlin R.B. Exposures of elderly volunteers with and without chronic obstructive pulmonary disease (COPD) to concentrated ambient fine particulate pollution. Inhal. Toxicol. 16 (2004) 731-744
62. Kendall M., Brown L., and Trought K. Molecular adsorption at particle surfaces: a PM toxicity mediation mechanism. Inhal. Toxicol. 16 Suppl. 1 (2004) 99-105
63. Gallagher J., Sams II R., Inmon J., Gelein R., Elder A., Oberdorster G., and Prahalad A.K. Formation of 8-oxo-7,8-dihydro-2′-deoxyguanosine in rat lung DNA following subchronic inhalation of carbon black. Toxicol. Appl. Pharmacol. 190 (2003) 224-231
64. Sorensen M., Schins R.P., Hertel O., and Loft S. Transition metals in personal samples of PM2.5 and oxidative stress in human volunteers. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1340-1343
65. Peters A., Dockery D.W., Heinrich J., and Wichmann H.E. Short-term effects of particulate air pollution on respiratory morbidity in asthmatic children. Eur. Respir. J. 10 (1997) 872-879
66. Schwartz J. PM10, ozone, and hospital admissions for the elderly in Minneapolis-St. Paul, Minnesota. Arch. Environ. Health. 49 (1994) 366-374
67. Hattis D., Russ A., Goble R., Banati P., and Chu M. Human interindividual variability in susceptibility to airborne particles. Risk Anal. 21 (2001) 585-599
68. Ohtsuka Y., Clarke R.W., Mitzner W., Brunson K., Jakab G.J., and Kleeberger S.R. Interstrain variation in murine susceptibility to inhaled acid-coated particles. Am. J. Physiol. Lung Cell. Mol. Physiol. 278 (2000) L469-L476
69. Kleeberger S.R., and Ohtsuka Y. Gene-particulate matter-health interactions. Toxicol. Appl. Pharmacol. 207 (2005) 276-281
70. Ohtsuka Y., Brunson K.J., Jedlicka A.E., Mitzner W., Clarke R.W., Zhang L.Y., Eleff S.M., and Kleeberger S.R. Genetic linkage analysis of susceptibility to particle exposure in mice. Am. J. Respir. Cell Mol. Biol. 22 (2000) 574-581
71. Dreher K.L., Jaskot R.H., Lehmann J.R., Richards J.H., McGee J.K., Ghio A.J., and Costa D.L. Soluble transition metals mediate residual oil fly ash induced acute lung injury. J. Toxicol. Environ. Health 50 (1997) 285-305
72. Lambert A.L., Dong W., Selgrade M.K., and Gilmour M.I. Enhanced allergic sensitization by residual oil fly ash particles is mediated by soluble metal constituents. Toxicol. Appl. Pharmacol. 165 (2000) 84-93
73. Ghio A.J., Silbajoris R., Carson J.L., and Samet J.M. Biologic effects of oil fly ash. Environ. Health Perspect. 110 Suppl. 1 (2002) 89-94
74. Carter J.D., Ghio A.J., Samet J.M., and Devlin R.B. Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent. Toxicol. Appl. Pharmacol. 146 (1997) 180-188
75. van Eeden S.F., Tan W.C., Suwa T., Mukae H., Terashima T., Fujii T., Qui D., Vincent R., and Hogg J.C. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am. J. Respir. Crit. Care Med. 164 (2001) 826-830
76. Cho H.Y., Jedlicka A.E., Clarke R., and Kleeberger S.R. Role of Toll-like receptor-4 in genetic susceptibility to lung injury induced by residual oil fly ash. Physiol. Genomics 22 (2005) 108-117
77. Gilmour P.S., Schladweiler M.C., Richards J.H., Ledbetter A.D., and Kodavanti U.P. Hypertensive rats are susceptible to TLR4-mediated signaling following exposure to combustion source particulate matter. Inhal. Toxicol. 16 Suppl. 1 (2004) 5-18
78. Hollingsworth II J.W., Cook D.N., Brass D.M., Walker J.K., Morgan D.L., Foster W.M., and Schwartz D.A. The role of Toll-like receptor 4 in environmental airway injury in mice. Am. J. Respir. Crit. Care Med. 170 (2004) 126-132
79. Weller B.L., Witschi H., and Pinkerton K.E. Quantitation and localization of pulmonary manganese superoxide dismutase and tumor necrosis factor alpha following exposure to ozone and nitrogen dioxide. Toxicol. Sci. 54 (2000) 452-461
80. Prows D.R., and Leikauf G.D. Quantitative trait analysis of nickel-induced acute lung injury in mice. Am. J. Respir. Cell Mol. Biol. 24 (2001) 740-746
81. Wesselkamper S.C., Case L.M., Henning L.N., Borchers M.T., Tichelaar J.W., Mason J.M., Dragin N., Medvedovic M., Sartor M.A., Tomlinson C.R., and Leikauf G.D. Gene expression changes during the development of acute lung injury: role of transforming growth factor beta. Am. J. Respir. Crit. Care Med. 172 (2005) 1399-1411
82. Mallakin A., Kutcher L.W., McDowell S.A., Kong S., Schuster R., Lentsch A.B., Aronow B.J., Leikauf G.D., and Waltz S.E. Gene expression profiles of Mst1r-deficient mice during nickel-induced acute lung injury. Am. J. Respir. Cell Mol. Biol. 34 (2006) 15-27
83. Wesselkamper S.C., Chen L.C., Kleeberger S.R., and Gordon T. Genetic variability in the development of pulmonary tolerance to inhaled pollutants in inbred mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L1200-L1209
84. Wesselkamper S.C., Chen L.C., and Gordon T. Quantitative trait analysis of the development of pulmonary tolerance to inhaled zinc oxide in mice. Respir. Res. 6 (2005) 73
85. Sebastiani G., Leveque G., Lariviere L., Laroche L., Skamene E., Gros P., and Malo D. Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics 64 (2000) 230-240
86. Otterbein L.E., Kolls J.K., Mantell L.L., Cook J.L., Alam J., and Choi A.M. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. 103 (1999) 1047-1054
87. Thompson K., Menzies S., Muckenthaler M., Torti F.M., Wood T., Torti S.V., Hentze M.W., Beard J., and Connor J. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J. Neurosci. Res. 71 (2003) 46-63
88. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342 (2000) 1334-1349
89. Crapo J.D. Morphologic changes in pulmonary oxygen toxicity. Annu. Rev. Physiol. 48 (1986) 721-731
90. Hudak B.B., Zhang L.Y., and Kleeberger S.R. Inter-strain variation in susceptibility to hyperoxic injury of murine airways. Pharmacogenetics 3 (1993) 135-143
91. Cho H.Y., Jedlicka A.E., Reddy S.P., Zhang L.Y., Kensler T.W., and Kleeberger S.R. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am. J. Respir. Cell Mol. Biol. 26 (2002) 42-51
92. Cho H.Y., Jedlicka A.E., Reddy S.P., Kensler T.W., Yamamoto M., Zhang L.Y., and Kleeberger S.R. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26 (2002) 175-182
93. Cho H.Y., Reddy S.P., Debiase A., Yamamoto M., and Kleeberger S.R. Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic. Biol. Med. 38 (2005) 325-343
94. Asikainen T.M., Huang T.T., Taskinen E., Levonen A.L., Carlson E., Lapatto R., Epstein C.J., and Raivio K.O. Increased sensitivity of homozygous Sod2 mutant mice to oxygen toxicity. Free Radic. Biol. Med. 32 (2002) 175-186
95. Barrios R., Shi Z.Z., Kala S.V., Wiseman A.L., Welty S.E., Kala G., Bahler A.A., Ou C.N., and Lieberman M.W. Oxygen-induced pulmonary injury in gamma-glutamyl transpeptidase-deficient mice. Lung 179 (2001) 319-330
96. Danel C., Erzurum S.C., Prayssac P., Eissa N.T., Crystal R.G., Herve P., Baudet B., Mazmanian M., and Lemarchand P. Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum. Gene Ther. 9 (1998) 1487-1496
97. Folz R.J., Abushamaa A.M., and Suliman H.B. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J. Clin. Invest. 103 (1999) 1055-1066
98. Ho Y.S., Vincent R., Dey M.S., Slot J.W., and Crapo J.D. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am. J. Respir. Cell Mol. Biol. 18 (1998) 538-547
99. Jean J.C., Liu Y., Brown L.A., Marc R.E., Klings E., and Joyce-Brady M. Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 283 (2002) L766-L776
100. Taylor J.L., Carraway M.S., and Piantadosi C.A. Lung-specific induction of heme oxygenase-1 and hyperoxic lung injury. Am. J. Physiol. 274 (1998) L582-L590
101. Tian L., White J.E., Lin H.Y., Haran V.S., Sacco J., Chikkappa G., Davis F.B., Davis P.J., and Tsan M.F. Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Am. J. Physiol. 275 (1998) C740-C747
102. Wang Y., Manevich Y., Feinstein S.I., and Fisher A.B. Adenovirus-mediated transfer of the 1-cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004) L1188-L1193
103. Yang F., Coalson J.J., Bobb H.H., Carter J.D., Banu J., and Ghio A.J. Resistance of hypotransferrinemic mice to hyperoxia-induced lung injury. Am. J. Physiol. 277 (1999) L1214-L1223
104. Cho H.Y., Reddy S.P., Yamamoto M., and Kleeberger S.R. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J. 18 (2004) 1258-1260
105. Hackett N.R., Heguy A., Harvey B.G., O'Connor T.P., Luettich K., Flieder D.B., Kaplan R., and Crystal R.G. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am. J. Respir. Cell Mol. Biol. 29 (2003) 331-343
106. Ishii Y., Itoh K., Morishima Y., Kimura T., Kiwamoto T., Iizuka T., Hegab A.E., Hosoya T., Nomura A., Sakamoto T., Yamamoto M., and Sekizawa K. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J. Immunol. 175 (2005) 6968-6975
107. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., Yamamoto M., Petrache I., Tuder R.M., and Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114 (2004) 1248-1259
108. Rangasamy T., Guo J., Mitzner W.A., Roman J., Singh A., Fryer A.D., Yamamoto M., Kensler T.W., Tuder R.M., Georas S.N., and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 202 (2005) 47-59
109. Bouros D., and Antoniou K.M. Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur. Respir. J. 26 (2005) 693-702
110. Hecht S.M. DNA strand scission by activated bleomycin group antibiotics. Fed. Proc. 45 (1986) 2784-2791
111. Ishida R., and Takahashi T. Increased DNA chain breakage by combined action of bleomycin and superoxide radical. Biochem. Biophys. Res. Commun. 66 (1975) 1432-1438
112. Geara F.B., Komaki R., Tucker S.L., Travis E.L., and Cox J.D. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation. Int. J. Radiat. Oncol. Biol. Phys. 41 (1998) 279-286
113. Marshall R.P., Puddicombe A., Cookson W.O., and Laurent G.J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 55 (2000) 143-146
114. Haston C.K., and Travis E.L. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res. 57 (1997) 5286-5291
115. Haston C.K., Zhou X., Gumbiner-Russo L., Irani R., Dejournett R., Gu X., Weil M., Amos C.I., and Travis E.L. Universal and radiation-specific loci influence murine susceptibility to radiation-induced pulmonary fibrosis. Cancer Res. 62 (2002) 3782-3788
116. Haston C.K., Wang M., Dejournett R.E., Zhou X., Ni D., Gu X., King T.M., Weil M.M., Newman R.A., Amos C.I., and Travis E.L. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum. Mol. Genet. 11 (2002) 1855-1863
117. Lemay A.M., and Haston C.K. Bleomycin-induced pulmonary fibrosis susceptibility genes in AxB/BxA recombinant congenic mice. Physiol. Genomics 23 (2005) 54-61